{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-037254","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2024-09-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.235710+00:00","generated_at":"2026-05-31T02:49:06.620860+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Vivos Therapeutics prices $4.3M registered direct offering of 1,363,812 shares at $3.15/share","bullets":["Gross proceeds of ~$4.3M before fees; closing expected Sept 20, 2024.","Placement agent H.C. Wainwright receives 7% cash fee plus 95,467 warrants at $3.9375.","Net proceeds to be used for working capital and general corporate purposes.","No warrants issued to investors; offering priced at-the-market under Nasdaq rules.","Shares sold under effective shelf registration statement (File No. 333-262554)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-037254","json":"https://secwatch.observer/filing/0001493152-24-037254.json","markdown":"https://secwatch.observer/filing/0001493152-24-037254.md","text":"https://secwatch.observer/filing/0001493152-24-037254.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224037254/0001493152-24-037254-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224037254/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:49:06.620860+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}